Login / Signup

Germline Variants in Cancer Genes from Young Breast Cancer Mexican Patients.

Liliana Gómez Flores-RamosAngélica Leticia Barraza-ArellanoAlejandro MoharMiguel Trujillo-MartínezLizbeth GrimaldoRocío Ortíz-LópezVíctor Treviño-Alvarado
Published in: Cancers (2022)
Breast cancer (BC) is one of the most frequent cancer types in women worldwide. About 7% is diagnosed in young women (YBC) less than 40 years old. In Mexico, however, YBC reaches 15% suggesting a higher genetic susceptibility. There have been some reports of germline variants in YBC across the world. However, there is only one report from a Mexican population, which is not restricted by age and limited to a panel of 143 genes resulting in 15% of patients carrying putatively pathogenic variants. Nevertheless, expanding the analysis to whole exome involves using more complex tools to determine which genes and variants could be pathogenic. We used germline whole exome sequencing combined with the PeCanPie tool to analyze exome variants in 115 YBC patients. Our results showed that we were able to identify 49 high likely pathogenic variants involving 40 genes on 34% of patients. We noted many genes already reported in BC and YBC worldwide, such as BRCA1 , BRCA2 , ATM , CHEK2 , PALB2 , and POLQ , but also others not commonly reported in YBC in Latin America, such as CLTCL1 , DDX3X , ERCC6 , FANCE , and NFKBIE . We show further supporting and controversial evidence for some of these genes. We conclude that exome sequencing combined with robust annotation tools and further analysis, can identify more genes and more patients affected by germline mutations in cancer.
Keyphrases